Cite
Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry.
MLA
Gwechenberger, Marianne, et al. “Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry.” JACC. Advances, vol. 3, no. 4, Mar. 2024, p. 100880. EBSCOhost, https://doi.org/10.1016/j.jacadv.2024.100880.
APA
Gwechenberger, M., Barón-Esquivias, G., de Vries, T. A. C., Siller-Matula, J. M., Manu, M. C., Souza, J. A. G., Wienerroither, S., Pecen, L., de Groot, J. R., De Caterina, R., & Kirchhof, P. (2024). Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry. JACC. Advances, 3(4), 100880. https://doi.org/10.1016/j.jacadv.2024.100880
Chicago
Gwechenberger, Marianne, Gonzalo Barón-Esquivias, Tim A C de Vries, Jolanta M Siller-Matula, Marius C Manu, José A G Souza, Sebastian Wienerroither, et al. 2024. “Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry.” JACC. Advances 3 (4): 100880. doi:10.1016/j.jacadv.2024.100880.